Home » Topics » BioWorld Science

BioWorld Science
RSS

Kronos Bio synthesizes new PROTAC CDK9 degradation inducers

June 2, 2022

New MAP4K 1inhibitors identified at Merck & Co.

June 2, 2022

Researchers present novel Hermansky-Pudlak syndrome murine model

June 2, 2022

Expanded collaboration research on COVID-19 protease inhibitors

June 2, 2022

Almac Discovery selects peptide-drug conjugate ADP-c389 for preclinical development

June 2, 2022

SRSF9 overexpression correlates with CRC lymph node metastasis and Dukes stage

June 1, 2022

Olverembatinib, ponatinib identified as possible treatments for COVID-related cytokine storm

June 1, 2022

Close look illuminates ketamine's (relative) staying power

June 1, 2022

Cat model of Rdh5-associated retinopathy mimics the human phenotype

June 1, 2022

Anti-NOTCH3 treatment reverses experimental pulmonary arterial hypertension

June 1, 2022

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...